API
< Back to situations

[ORGANIZATION]

University of Chicago Harris School of Public Policy

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

344 clusters · 1318 sources · last updated

Latest: GLP-1 medications pose risks of muscle wastage and weight rebound

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt

Also covered in